CELZ CREATIVE MEDICAL TECHNOLOGY...

Nasdaq creativemedicaltechnology.com


$ 2.94 $ 0.05 (1.68 %)    

Friday, 07-Nov-2025 15:59:54 EST
QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ 3.02
$ 3.08
$ 2.76 x 25
$ 3.20 x 10
$ 2.90 - $ 3.28
$ 1.69 - $ 6.90
171,060
na
7.79M
$ -38.59
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-07-2025 09-30-2025 10-Q
2 08-08-2025 06-30-2025 10-Q
3 05-09-2025 03-31-2025 10-Q
4 03-14-2025 12-31-2024 10-K
5 11-08-2024 09-30-2024 10-Q
6 08-09-2024 06-30-2024 10-Q
7 05-10-2024 03-31-2024 10-Q
8 03-22-2024 12-31-2023 10-K
9 11-14-2023 09-30-2023 10-Q
10 08-11-2023 06-30-2023 10-Q
11 05-12-2023 03-31-2023 10-Q
12 03-31-2023 12-31-2022 10-K
13 11-10-2022 09-30-2022 10-Q
14 08-12-2022 06-30-2022 10-Q
15 05-13-2022 03-31-2022 10-Q
16 03-30-2022 12-31-2021 10-K
17 11-15-2021 09-30-2021 10-Q
18 08-16-2021 06-30-2021 10-Q
19 05-17-2021 03-31-2021 10-Q
20 03-17-2021 12-31-2020 10-K
21 11-13-2020 09-30-2020 10-Q
22 08-14-2020 06-30-2020 10-Q
23 05-15-2020 03-31-2020 10-Q
24 04-06-2020 12-31-2019 10-K
25 11-14-2019 09-30-2019 10-Q
26 08-13-2019 06-30-2019 10-Q
27 05-20-2019 03-31-2019 10-Q
28 04-01-2019 12-31-2018 10-K
29 11-14-2018 09-30-2018 10-Q
30 08-14-2018 06-30-2018 10-Q
31 05-21-2018 03-31-2018 10-Q
32 03-29-2018 12-31-2017 10-K
33 11-13-2017 09-30-2017 10-Q
34 08-14-2017 06-30-2017 10-Q
35 05-10-2017 03-31-2017 10-Q
36 02-13-2017 12-31-2016 10-K
37 11-10-2016 09-30-2016 10-Q
38 08-19-2016 06-30-2016 10-Q
39 05-13-2016 03-31-2016 10-Q
40 04-14-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 creative-medical-technology-launches-national-biodefense-inc-veterans-initiative-to-combat-burn-pit-exposure-using-ai-and-regenerative-cell-therapy

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) ("Creative Medical" or the "Company"), a clinical-stag...

 creative-medical-technologies-will-be-issued-us-patent-number-12391925-tomorrow-titled-prevention-andor-treatment-of-type-1-diabetes-by-augmentation-of-myeloid-suppressor-cell-activity

https://x.com/patentgrants/status/1957532080155562158?s=46&t=dtUiyC3dUs5yGRgT9qYHWg

 us-stocks-likely-to-open-lower-a-day-after-nasdaq-hits-record-high-nvidia-kellogg-klotho-in-focus

U.S. stock futures declined on Thursday after ending higher on Wednesday. Futures of major benchmark indices were trading lower.

 creative-medical-technology-has-received-a-notice-of-allowance-for-a-us-patent-titled-treatment-of-heart-failure-andor-post-infarct-pathological-remodeling-by-ex-vivo-reprogrammed-immune-cells

https://patentcenter.uspto.gov/applications/17559970/ifw/docs

 creative-medical-technology-announces-ovastem-shows-85-hormonal-improvement-70-success-orphan-drug-designation-filed

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ), a leading biotechnology innovator in regenerative medicine, enthusias...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION